BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 8649773)

  • 1. Transcriptional repression by the proto-oncogene BCL-6.
    Seyfert VL; Allman D; He Y; Staudt LM
    Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
    Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
    Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
    Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
    Huynh KD; Bardwell VJ
    Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL6 can repress transcription from the human immunodeficiency virus type I promoter/enhancer region.
    Baron BW; Desai M; Baber LJ; Paras L; Zhang Q; Sadhu A; Duguay S; Nucifora G; McKeithan TW; Zeleznik-Le N
    Genes Chromosomes Cancer; 1997 May; 19(1):14-21. PubMed ID: 9135990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
    Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
    Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6.
    Zhang W; Mi J; Li N; Sui L; Wan T; Zhang J; Chen T; Cao X
    Biochem Biophys Res Commun; 2001 Apr; 282(4):1067-73. PubMed ID: 11352661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common DNA-binding site for SZF1 and the BRCA1-associated zinc finger protein, ZBRK1.
    Peng H; Zheng L; Lee WH; Rux JJ; Rauscher FJ
    Cancer Res; 2002 Jul; 62(13):3773-81. PubMed ID: 12097288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the isoforms of MOVO zinc finger protein, a mouse homologue of Drosophila Ovo, as transcription factors.
    Unezaki S; Nishizawa M; Okuda-Ashitaka E; Masu Y; Mukai M; Kobayashi S; Sawamoto K; Okano H; Ito S
    Gene; 2004 Jul; 336(1):47-58. PubMed ID: 15225875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCL-6 in diffuse large-cell lymphomas.
    Dalla-Favera R; Ye BH; Cattoretti G; Lo Coco F; Chang CC; Zhang J; Migliazza A; Cechova K; Niu H; Chaganti S; Chen W; Louie DC; Offit K; Chaganti RS
    Important Adv Oncol; 1996; ():139-48. PubMed ID: 8791133
    [No Abstract]   [Full Text] [Related]  

  • 11. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
    Chang CC; Ye BH; Chaganti RS; Dalla-Favera R
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6947-52. PubMed ID: 8692924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of transcriptional activities of AP1 and SRE by a novel zinc finger protein ZNF445.
    Luo K; Yuan J; Shan Y; Li J; Xu M; Cui Y; Tang W; Wan B; Zhang N; Wu Y; Yu L
    Gene; 2006 Feb; 367():89-100. PubMed ID: 16368201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR; Gu W; Dalla-Favera R
    Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of mammalian transcriptional repressors.
    Thiel G; Lietz M; Bach K; Guethlein L; Cibelli G
    Biol Chem; 2001 Jun; 382(6):891-902. PubMed ID: 11501753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.
    Dennig J; Beato M; Suske G
    EMBO J; 1996 Oct; 15(20):5659-67. PubMed ID: 8896459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
    Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
    Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional domains of the TGF-beta-inducible transcription factor Tieg3 and detection of two putative nuclear localization signals within the zinc finger DNA-binding domain.
    Spittau B; Wang Z; Boinska D; Krieglstein K
    J Cell Biochem; 2007 Jun; 101(3):712-22. PubMed ID: 17252542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of a SV40 promoter specific artificial transcription factor].
    Zhao XH; Zhu XD; Liu J; Rao XJ; Huang PT
    Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):608-12. PubMed ID: 15969093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factors of the Sp1 family: interaction with E2F and regulation of the murine thymidine kinase promoter.
    Rotheneder H; Geymayer S; Haidweger E
    J Mol Biol; 1999 Nov; 293(5):1005-15. PubMed ID: 10547281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
    Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
    Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.